| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
S,S-Endo-lurasidone
|
1318074-27-9 |
S,S-内型鲁拉西酮盐酸盐
|
S,S-内型鲁拉西酮盐酸盐;(3AR,4R,7S,7AS)-2-[[(1S,2S)-2-[[4-(1,2-苯并异噻唑-3-基)-1-哌嗪基]甲基]环己基]甲基]六氢-4,7-甲桥-1H-异吲哚-1,3(2H)-二酮;LURASIDONE-24;S,S-ENDO-鲁拉西酮;LURASIDONE ISOMER (S,S-ENDO);鲁拉西酮杂质28
|
C28H36N4O2S |
492.67604 | |
|
Lurasidone Impurity 2 Monomer
|
1318074-18-8 |
LURASIDONE ISOMER (CIS)
|
鲁拉西酮杂质13;LURASIDONE ISOMER (CIS);LURASIDONE-10;(3AR,4S,7R,7AS)-2-[[(1R,2S)-2-[[4-(1,2-苯并异噻唑-3-基)-1-哌嗪基]甲基]环己基]甲基]六氢-4,7-甲桥-1H-异吲哚-1,3(2H)-二酮
|
C28H37ClN4O2S |
529.13698 | |
|
ERYTHROMYCIN OXIME
|
13127-18-9 |
红霉素A肟
|
罗红霉素杂质 C;红霉素A肟;红霉素肟;红霉素A肟 1KG;克拉霉素EP杂质J;9-红霉素A肟克拉霉素杂质J;克拉霉素杂质J
|
C37H68N2O13 |
748.94 | 204-040-1 |
|
Clavulanate EP Impurity E
|
1260617-10-4 |
克拉维酸盐EP杂质
|
克拉维酸盐EP杂质;克拉维酸EP杂质E
|
C16H18N2O10 |
398.32152 | |
|
Edoxaban Impurity 26
|
1255529-25-9 |
依度沙班杂质
|
依度沙班杂质RSS;依度沙班杂质10;依度沙班异构体杂质B;EDOXABAN-15
|
C24H30ClN7O4S |
548.0575 | |
|
Edoxaban Impurity 25
|
1255529-24-8 |
依度沙班杂质RRR
|
依多沙班杂质1;EDOXABAN-17;依杜沙班杂质;依度沙班杂质RRR
|
C24H30ClN7O4S |
548.0575 | |
|
Ticagrelor Related Compound 45 (DP3)
|
1251765-07-7 |
替格瑞洛杂质H
|
替格瑞洛杂质B:氨基脱保护杂质;替格瑞洛杂质H;替格瑞洛相关化合物45(DP3);TICAGRELOR-8;替卡格雷杂质H(UL134);替格瑞洛杂质45;替卡格雷相关化合物45(DP3)
|
C14H22N6O4S |
370.42728 | |
|
Posaconazole Diastereoisomer 1
|
1246391-73-0 |
泊沙康唑杂质
|
泊沙康唑杂质15;(3S,5S,2S,3S)-泊沙康唑
|
C37H42F2N8O4 |
700.7773864 | |
|
Tedizolid Impurity 25
|
1239662-46-4 |
特地唑胺杂质
|
特地唑胺杂质4;TOREZOLID-30;特地唑胺杂质14:羟基氯代杂质;(5R)-5-(氯甲基)-3-[3-氟-4-[6-(2-甲基-2H-四唑-5-基)-3-吡啶基]苯基]-2-恶唑烷酮;磷酸特地唑胺氯代物;泰地唑胺杂质25;泰地唑胺杂质31;特地唑胺杂质32
|
C17H14ClFN6O2 |
388.783463 | |
|
Febuxostat Related Compound (Febuxostat Impurity 4 )
|
1239233-86-3 |
非布索坦相关物质
|
FEBUXOSTAT-1;非布索坦相关物质;2-[3-(氨基羰基)-4-(2-甲基丙氧基)苯基]-4-甲基-5-噻唑羧酸;非布索坦杂质A;非布司他杂质D;非布司他杂质12;非布索坦杂质121;非布索坦酰胺杂质
|
C16H18N2O4S |
334.39012 | |
|
Posaconazole Diastereoisomer 3 (S,R,R,R)
|
1229428-89-0 |
泊沙康唑杂质
|
泊沙康唑杂质;泊沙康唑杂质(19个);(3R,5S,2R,3R)-泊沙康唑;泊沙康唑非对映异构体3(S,R,R)
|
|||
|
Mosapride Citric Amide
|
1215825-20-9 |
普拉克索杂质E
|
普拉克索杂质E;莫沙必利柠檬酰胺;莫沙必利杂质13;莫沙必利杂质M
|
C27H31ClFN3O9 |
596.0011432 | |
|
PSI-7976
|
1190308-01-0 |
索菲布韦杂质
|
磷异构体;索非布韦杂质01;索非布韦杂质19;PSI-7976;PSI7977杂质A
|
C22H29FN3O9P |
529.4525242 | |
|
Levofloxacin Related Compound A
|
117707-40-1 |
左氧氟沙星相关物质A
|
盐酸左氧氟沙星杂质Ⅲ(杂质E)(3RS)-9-氟-3-甲基-7-氧代-10-(1-哌嗪基)-2,3-二氢-7H-吡啶并[1,2,3-DE]-1,4-苯并噁嗪-6-羧酸;氧氟沙星杂质 II(杂质E)(3RS)-9-氟-3-甲基-7-氧代-10-(1-哌嗪基)-2,3-二氢-7H-吡啶并-[1,2,3-de]-1,4-苯并噁嗪-6-羧酸;氧氟沙星杂质 II(杂质E)(3RS)-9-氟-3-甲基-7-氧代-10-(1-哌嗪基)-2,3-二氢-7H-吡啶并-[1,4-苯并噁嗪-6-羧酸;左氧氟沙星相关物质A;左旋氧氟沙星相关物质A;左旋氧氟沙星USP相关物质A;LEVOFLOXACIN-1;左氧氟沙星杂质Ⅲ左氧氟沙星杂质E(3RS)-9-氟-3-甲基-7-氧代-10-(1-哌嗪基)-2,3-de]-1,4-苯并噁嗪-6-羧酸
|
C17H18FN3O4 |
347.3409232 | |
|
Levofloxacin Impurity 22
|
117620-84-5 |
左氧氟沙星杂质J
|
左氧氟沙星杂质 26;LEVOFLOXACIN-10;左氧氟沙星杂质J
|
C13H10FNO4 |
263.221203 | |
|
Paliperidone Impurity 14
|
1172297-96-9 |
利培酮杂质2
|
伊潘立酮杂质20 盐酸盐;盐酸伊潘立酮杂质8;伊潘立酮杂质20;伊潘立酮杂质20对照品;4-(2,5-二氟苯甲酰)哌啶盐酸;利培酮杂质20
|
C12H14ClF2NO |
261.695466 | |
|
Pramipexole Impurity C
|
1147937-31-2 |
普拉克索杂质18
|
PRAMIPEXOLE IMPURITY F;(S)-N6,N6-DIPROPYL-4,5,6,7-TETRAHYDROBENZO[D]THIAZOLE-2,6-DIAMINE
|
C8H10N4O3S |
||
|
Neratinib Impurity 8
|
1144516-21-1 |
来那替尼
|
来那替尼杂质PRQ;来那替尼杂质8;来那替尼杂质5
|
C29H27ClN6O2 |
527 | |
|
Bortezomib Impurity (S,S-Isomer)
|
1132709-14-8 |
硼替佐米杂质E
|
S,S-异构体;硼替佐米杂质E;BORTEZOMIB杂质 E;(1S,2S)-硼替佐米杂质;硼替佐米杂质 19;硼替佐米杂质PS619;硼替佐米杂质1(S,S-异构体)
|
C19H25BN4O4 |
384.2372 | |
|
Valsartan Ethyl Ester
|
1111177-30-0 |
缬沙坦杂质Ⅱ
|
N-戊酰基-N-[2'-(1H-四唑-5-基)[1,1'-联苯基]-4-基甲基]-L-缬氨酸乙酯;原研523-10;VALSARTAN-2;缬沙坦-523-10;缬沙坦杂质21
|
C26H33N5O3 |
463.57192 |
药智官方微信
药智官方微博
